Rho kinase inhibitor (Kalypsys/Alcon)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRho kinase inhibitor (Kalypsys/Alcon)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlcon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalypsys IncAlcon Inc
Active IndicationsN/A
Inactive IndicationsGlaucomaOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A